Abiopharma

GENTHERM INC (THRM) Files Form 10-Q

Director Dietz Diane M. 🟢 acquired 2.8K shares of WHIRLPOOL CORP /DE/ (WHR) Transaction Date: Apr 21, 2026 | Filing ID: 000002

(99% Neutral) ZURA BIO LTD (ZURA) Announces New Board Appointment

(99% Neutral) JEFFERSON CAPITAL, INC. / DE (JCAP) Announces Business Combination

(99% Neutral) RB GLOBAL INC. (RBA) Announces Business Combination

(10% Negative) BAYCOM CORP (BCML) Reports Q2 2026 Financial Results

Director Buckner Judith K. 🟢 acquired 2.8K shares of WHIRLPOOL CORP /DE/ (WHR) Transaction Date: Apr 21, 2026 | Filing ID: 000021

📋 JENNIFER JARRETT (Officer) plans to sell 54K shares of ARCUS BIOSCIENCES, INC. (at $25.20 each, total $1.4M) Filed: Apr 23, 2026 | ID: 003724

📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 15K shares of Dyne Therapeutics, Inc. (at $19.67 each, total $298K) Filed: Apr 23, 2026 | ID: 026891

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 19K shares of Dyne Therapeutics, Inc. (at $19.67 each, total $379K) Filed: Apr 23, 2026 | ID: 026890

Director Stangl Rolf 🟡 adjusted position in 0 shares (1 derivative) of Reynolds Consumer Products Inc. (REYN) Transaction Date: Apr 23, 2026 | Filing ID: 000004

📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 38K shares of Dyne Therapeutics, Inc. (at $19.67 each, total $754K) Filed: Apr 23, 2026 | ID: 026887

Director GOTTSCHALK MARLA C 🟡 adjusted position in 0 shares (1 derivative) of Reynolds Consumer Products Inc. (REYN) Transaction Date: Apr 23, 2026 | Filing ID: 000002

📋 Atlas Venture Associates XI, LP (Shareholder) plans to sell 377 shares of Dyne Therapeutics, Inc. (at $19.67 each, total $7K) Filed: Apr 23, 2026 | ID: 026885

Hilltop Holdings Inc. Announces Financial Results for First Quarter 2026